• Profile
Close
Sign Up / Log In
Journal Summaries
Oncology
  Leukemia/Lymphoma

Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: A single-arm, phase 2 trial

The Lancet Haematology | Dec 18, 2019 Leukemia/Lymphoma

Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study

Cancer | Dec 16, 2019 Leukemia/Lymphoma

Characterization of tumor microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas

Virchows Archiv | Dec 16, 2019 Leukemia/Lymphoma

IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications

Virchows Archiv | Dec 15, 2019 Leukemia/Lymphoma

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): Interim analysis of an open-label, single-arm, phase 1–2 trial

The Lancet Oncology | Dec 13, 2019 Leukemia/Lymphoma

Evaluation of the MD Anderson tumor score for diffuse large B-cell lymphoma in the rituximab era

European Journal of Haematology | Dec 13, 2019 Leukemia/Lymphoma

An international multicenter retrospective analysis of patients with extranodal marginal zone lymphoma and histologically confirmed central nervous system and dural involvement

Cancer Medicine | Dec 13, 2019 Leukemia/Lymphoma

Randomized, double-blind, pharmacokinetic equivalence trial comparing DRL-rituximab with MabThera in patients with diffuse large B-cell lymphoma

Journal of Global Oncology | Dec 13, 2019 Leukemia/Lymphoma

Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosis

Journal of the European Academy of Dermatology and Venereology | Dec 12, 2019 Leukemia/Lymphoma

Atezolizumab for children and young adults with previously treated solid tumours, non-Hodgkin lymphoma, and Hodgkin lymphoma (iMATRIX): A multicentre phase 1–2 study

The Lancet Oncology | Dec 11, 2019 Leukemia/Lymphoma

1 … 18 20 22 … 81
Most read this week
1

BRI or BMI: What is More Efficient?
Placeholder
2

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions
Placeholder
3

These Popular Snacks Linked a Decline in Mental Health
Placeholder
4

Awareness for COPD: MCQ challenge
Placeholder
5

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies
Placeholder
Bannerimg

A variety of information related to Medicine and Health Care. It's all here.

Select Topic

x
M3 app logo
Choose easy access to M3 India from your mobile!

Add to home

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay